{"transactions":[{"id":1322896,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-23T09:18:56.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split."}],"balance_after":975,"derivative":{"exercise_price":4.14,"expiration_date":"2029-12-19","underlying":"Common shares","underlying_shares":550},"source":{"system":"sec-edgar","filing":"0001213900-24-111548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761920/000121390024111548/ownership.xml","form_type":"4"}},{"id":1700103,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-26T13:05:14.000Z","date":"2023-12-23","kind":"grant","planned":false,"acquired":true,"shares":7100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner."}],"balance_after":8500,"derivative":{"exercise_price":0.37,"expiration_date":"2028-12-22","underlying":"Common shares","underlying_shares":7100},"source":{"system":"sec-edgar","filing":"0001213900-23-098488","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761920/000121390023098488/ownership.xml","form_type":"4"}},{"id":2081799,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T16:50:47.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":1400,"derivative":{"exercise_price":1.78,"expiration_date":"2027-12-15","underlying":"Common shares","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001213900-22-080962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761920/000121390022080962/ownership.xml","form_type":"4"}},{"id":2263887,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-05-19T16:24:33.000Z","date":"2022-05-17","kind":"grant","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on May 17, 2022 and will vest monthly, in arrears, as follows: (i) 390 stock options will vest on the 17th day of each month for 35 months, and (ii) 350 stock options will vest on May 17, 2025 (the three year anniversary of Grant date)."}],"balance_after":14000,"derivative":{"exercise_price":0.8,"expiration_date":"2027-05-16","underlying":"Common Shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001213900-22-028300","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761920/000121390022028300/ownership.xml","form_type":"4"}},{"id":2461782,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-12-22T08:17:10.000Z","date":"2021-12-15","kind":"tax_withholding","acquired":false,"shares":1985,"price":17.92,"value":35571.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represent restricted stock units withheld by the Company under the net share settlement method to cover certain taxes due related to retirement eligibility, as follows: (i) 487 granted November 4, 2021; and (ii) 1,498 granted November 15, 2021."}],"balance_after":60929,"source":{"system":"sec-edgar","filing":"0001127602-21-031730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221031730/form4.xml","form_type":"4"}},{"id":2470786,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-12-16T16:38:54.000Z","date":"2021-11-15","kind":"tax_withholding","acquired":false,"shares":3807,"price":20.16,"value":76749.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represent restricted stock units withheld by the Company under the net share settlement method to cover certain taxes due upon vesting of grants, as follows:  (i) 1,523 granted November 8, 2017; and (ii) 2,284 granted November 15, 2018."}],"balance_after":62914,"source":{"system":"sec-edgar","filing":"0001127602-21-031110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221031110/form4.xml","form_type":"4"}},{"id":2511899,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-11-16T15:58:18.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":32557,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 1,200 on September 16, 2022; (ii) 20,534 on November 15, 2022; and (iii) 10,823 on November 15, 2023."}],"balance_after":66721,"source":{"system":"sec-edgar","filing":"0001127602-21-029298","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221029298/form4.xml","form_type":"4"}},{"id":2511898,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-11-16T15:58:18.000Z","date":"2021-11-15","kind":"other","acquired":false,"shares":32557,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer."}],"balance_after":34164,"source":{"system":"sec-edgar","filing":"0001127602-21-029298","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221029298/form4.xml","form_type":"4"}},{"id":2522132,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-11-08T16:09:15.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":11669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These non-qualified options are awarded under the 2021 Omnibus Award Plan and vest as follows: (i) 25% of the options awarded vest on November 4, 2022; and (ii) the remaining 75% of the options awarded vest pro rata each month from November 4, 2022 through November 4, 2025."}],"balance_after":11669,"derivative":{"exercise_price":18.88,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":11669},"source":{"system":"sec-edgar","filing":"0001127602-21-028575","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221028575/form4.xml","form_type":"4"}},{"id":2522131,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-11-08T16:09:15.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":10593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on November 4, 2025)."}],"balance_after":66721,"source":{"system":"sec-edgar","filing":"0001127602-21-028575","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221028575/form4.xml","form_type":"4"}},{"id":2873256,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-09T13:26:35.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested in four equal installments from the date of grant and were fully vested on March 24, 2020."}],"balance_after":0,"derivative":{"exercise_price":19.56,"expiration_date":"2026-03-24","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001127602-21-004586","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004586/form4.xml","form_type":"4"}},{"id":2873255,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-02-09T13:26:35.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":6254,"price":30,"value":187620.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020."}],"balance_after":56128,"source":{"system":"sec-edgar","filing":"0001127602-21-004586","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004586/form4.xml","form_type":"4"}},{"id":2873254,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-02-09T13:26:35.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":3750,"price":19.56,"value":73350.0,"ownership":{"direct":true},"balance_after":62382,"source":{"system":"sec-edgar","filing":"0001127602-21-004586","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004586/form4.xml","form_type":"4"}},{"id":2875624,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-08T10:21:28.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested in four equal installments from the date of grant and were fully vested on March 24, 2020."}],"balance_after":3750,"derivative":{"exercise_price":19.56,"expiration_date":"2026-03-24","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001127602-21-004269","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004269/form4.xml","form_type":"4"}},{"id":2875623,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-02-08T10:21:28.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":14250,"price":26.6053,"value":379125.525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prices range from $25.00 per share to $29.00 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer."}],"balance_after":58632,"source":{"system":"sec-edgar","filing":"0001127602-21-004269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004269/form4.xml","form_type":"4"}},{"id":2875622,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2021-02-08T10:21:28.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":11250,"price":19.56,"value":220050.0,"ownership":{"direct":true},"balance_after":72882,"source":{"system":"sec-edgar","filing":"0001127602-21-004269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760221004269/form4.xml","form_type":"4"}},{"id":2936897,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2020-12-21T14:22:48.000Z","date":"2020-11-16","kind":"tax_withholding","acquired":false,"shares":1991,"price":17.1065,"value":34059.0415,"ownership":{"direct":true},"balance_after":61632,"source":{"system":"sec-edgar","filing":"0001127602-20-032093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220032093/form4.xml","form_type":"4"}},{"id":2988914,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-11-09T13:28:04.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":12107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on 11/15/2023."}],"balance_after":12107,"derivative":{"exercise_price":18.48,"expiration_date":"2030-11-05","underlying":"Common Stock","underlying_shares":12107},"source":{"system":"sec-edgar","filing":"0001127602-20-028457","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220028457/form4.xml","form_type":"4"}},{"id":2988913,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2020-11-09T13:28:04.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":10823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on 11/15/2023."}],"balance_after":63623,"source":{"system":"sec-edgar","filing":"0001127602-20-028457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220028457/form4.xml","form_type":"4"}},{"id":3093984,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-07-02T13:52:00.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These non-qualified options were awarded under the 2004 Equity Compensation Plan and are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":19.71,"expiration_date":"2020-08-04","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001127602-20-020774","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220020774/form4.xml","form_type":"4"}},{"id":3093983,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2020-07-02T13:52:00.000Z","date":"2020-06-30","kind":"tax_withholding","acquired":false,"shares":1337,"price":23.29,"value":31138.73,"ownership":{"direct":true},"balance_after":52800,"source":{"system":"sec-edgar","filing":"0001127602-20-020774","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220020774/form4.xml","form_type":"4"}},{"id":3093982,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2020-07-02T13:52:00.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":1500,"price":19.71,"value":29565.0,"ownership":{"direct":true},"balance_after":54137,"source":{"system":"sec-edgar","filing":"0001127602-20-020774","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220020774/form4.xml","form_type":"4"}},{"id":3216665,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2020-03-11T13:47:25.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":1000,"price":6.955,"value":6955.0,"ownership":{"direct":true},"balance_after":52637,"source":{"system":"sec-edgar","filing":"0001127602-20-010224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220010224/form4.xml","form_type":"4"}},{"id":3216664,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2020-03-11T13:47:25.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":1000,"price":6.981,"value":6981.0,"ownership":{"direct":true},"balance_after":51637,"source":{"system":"sec-edgar","filing":"0001127602-20-010224","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760220010224/form4.xml","form_type":"4"}},{"id":3367235,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2019-11-19T14:12:51.000Z","date":"2019-11-18","kind":"tax_withholding","acquired":false,"shares":1968,"price":8.56,"value":16846.08,"ownership":{"direct":true},"balance_after":50637,"source":{"system":"sec-edgar","filing":"0001127602-19-033153","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219033153/form4.xml","form_type":"4"}},{"id":3382864,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Exec VP & CFO"}}],"security":"Common Stock","published_at":"2019-11-04T13:58:08.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":20534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2022."}],"balance_after":52605,"source":{"system":"sec-edgar","filing":"0001127602-19-031602","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219031602/form4.xml","form_type":"4"}},{"id":3408482,"issuer":{"id":117499,"kind":"organization","name":"MERIDIAN BIOSCIENCE INC","symbol":"VIVO"},"owners":[{"id":84826,"kind":"person","name":"Baldasare Bryan T","position":1,"cik":"0001761920","reported_name":"Baldasare Bryan T","relationship":{"officer":true,"officer_title":"Interim CFO & Chief Acctg Off"}}],"security":"Common Stock","published_at":"2019-09-23T14:50:19.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted under the 2012 Stock Incentive Plan in connection with the Company's acquisition of GenePOC Inc. and vest in full (i.e., 100%) on September 16, 2022."}],"balance_after":32071,"source":{"system":"sec-edgar","filing":"0001127602-19-028923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/794172/000112760219028923/form4.xml","form_type":"4"}}]}